[Insulin response and lipid and purine metabolic disorders in protodiabetes: evaluation of the changes induced with hypoglycemic drug treatment].
作者信息
Baraldi B, Carobbio C, Colloredo Mels G, Cocuzza E, Maestri G, D'Amore V, Angeli G
出版信息
Clin Ter. 1980 Apr 30;93(2):193-202.
PMID:7004754
Abstract
摘要
相似文献
1
2
[Oral hypoglycemic agents].
AMB Rev Assoc Med Bras. 1986 Nov-Dec;32(11-12):202-4.
3
Oral hypoglycemic agents.口服降糖药。
Dis Mon. 1976 Jan;22(4):1-35. doi: 10.1016/s0011-5029(76)80002-8.
4
[Clinical trial of a new oral antidiabetic: glypizide].[新型口服抗糖尿病药物：格列吡嗪的临床试验]
Rev Iber Endocrinol. 1974 Sep-Oct;21(125):459-62, 466-6, 469-70 passim.
5
[Behavior of serum insulin under the influence of glisoxepide with and without butylbiguanide].
Arzneimittelforschung. 1974 Mar;24(0):425-9.
6
[The therapeutic value of combined treatment with biguanides and sulfonylurea preparations in the presence of resistance to sulfanilamide drugs in diabetes mellitus patients].
Probl Endokrinol (Mosk). 1970 Nov-Dec;16(6):3-7.
7
Insulin, glucose and lipid levels in mild diabetics in relation to complications.
Adv Metab Disord. 1973;2:Suppl 2:83-101. doi: 10.1016/b978-0-12-027362-1.50016-9.
8
Glucose tolerance, plasma insulin and lipids in diabetic subjects before and after treatment with a new sulfonylurea compounds, Ro 6-4563.糖尿病患者在使用新型磺脲类化合物Ro 6-4563治疗前后的葡萄糖耐量、血浆胰岛素和血脂情况。
Eur J Clin Pharmacol. 1971 Dec;4(1):22-8. doi: 10.1007/BF00568894.
9
Oral hypoglycemic agents.
Adv Intern Med. 1979;24:53-70.
10
[On the clinical use of biguanides].关于双胍类药物的临床应用
Arzneimittelforschung. 1969 Apr;19(4):633-8.
Zotero 插件